Related Articles
JAK2 V617F detected in two B‑cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome‑negative myeloproliferative neoplasms: A report of two cases
Concomitant essential thrombocythemia with JAK2 V617F mutation in a patient with chronic myeloid leukemia with major molecular response with imatinib and long-term follow-up
A case of myeloproliferative neoplasm with a normal complete blood cell count: A novel problem of the JAK2 era
Prevalence of the Janus kinase 2 V617F mutation in Philadelphia‑negative myeloproliferative neoplasms in a Portuguese population
Advantages of the quenching probe method over other PCR-based methods for detection of the JAK2 V617F mutation